By | May 25, 2017

Consumers Beware: How ‘Approved’ Drugs Aren’t Always Safe

According to a study in the Journal of the American Medical Association (JAMA), of the 222 drugs that were approved by the Food and Drug Administration (FDA) from 2000 to 2010, 71… Read More

By | October 26, 2015

The History of Risperdal in the Pharmaceutical Marketplace

Also known by the generic name risperidone, Risperdal is a powerful, anti-psychotic medication prescribed to treat schizophrenia, autism and bipolar disorders in adults. Its manufacturer, Johnson & Johnson (J&J), has recently been making headlines,… Read More

By | March 24, 2015

The Ovarian Cancer Risk Factor You May Not Know

Ovarian cancer is one of the most common cancers among women. According to the American Cancer Society, an average woman’s risk of developing ovarian cancer is 1 in 75. Approximately 21,290 women… Read More

By | March 5, 2015

Testosterone Lawsuit News: FDA Orders Label Warnings on Testosterone Drugs

Testosterone therapy manufacturers must update the labels of all testosterone products to inform men about the increased risk of stroke, heart attack and death in patients taking testosterone, according to a testosterone… Read More

By | December 18, 2014

FDA Advisers Shown to Have Questionable Financial Ties

In July 2014, an adviser on a U.S. Food and Drug Administration (FDA) gynecology panel stepped down after he was questioned about conflicts of interest. It was later discovered that this panel… Read More

By | October 8, 2014

FDA Advises Drugmakers to Conduct Further Studies on Testosterone Heart Risk

An advisory panel to the U.S. Food and Drug Administration (FDA) recently voted 20-1 that further assessment of the health risks of testosterone therapy is needed among drugmakers. Among the panel, 16… Read More

By | June 10, 2014

Testosterone Therapy Lawsuits Consolidated Before One Judge

The U.S. Judicial Panel on Multidistrict Litigation has ordered the consolidation of all federal testosterone therapy lawsuits before the Hon. Matthew F. Kennelly in the Northern District of Illinois, U.S. District Court.… Read More

By | May 7, 2014

FDA Moves Transvaginal Mesh Devices to ‘High Risk’ Category

The U.S. Food and Drug Administration recently submitted a federal proposal to establish stricter safety requirements for transvaginal surgical mesh implants. The devices are often used to repair pelvic collapse in women, and… Read More

By | March 7, 2014

FDA Runs First Widespread Quality & Safety Evaluation on Generic Drugs

More than 80 percent of prescription drugs in the U.S. are being tested by the Food and Drug Administration (FDA) in its first widespread safety and quality evaluation. The effort will examine… Read More

By | February 24, 2014

Studies Point to Inconsistencies in FDA Approval Process

Three new studies took a deeper look into the U.S. Food and Drug Administration (FDA) regulatory process. Results from the studies found that FDA approval does not necessarily mean the medication or… Read More

Topics

PAST ARTICLES